Japan Chemical Daily

Japan's leading chemical industry newspaper

Log In

Takeda Pharmaceutical to Form New Joint Venture With PRA in Japan, Restructure Clinical Development

Filed Under: Pharma Tagged With: , ,

Takeda Pharmaceutical Co. Ltd. (TYO:4502) recently announced a new clinical development approach in Japan that it will run in partnership…...

Please subscribe to read the full story.

Subscribe Free Trial

Related Articles:

Coronavirus Report – Part 27: Pandemic Sees Clinical Trials for New Drugs Suspended, Postponed
Coronavirus Report – Part 27: Pandemic Sees Clinical Trials…
Coronavirus Report – Part 77: Japan’s Pharmaceutical Companies Move in Quick Order to Treat Infection
Coronavirus Report – Part 77: Japan’s Pharmaceutical…
Concerns Arise for Pharmaceutical Supply Chain Amid Crisis in Ukraine
Concerns Arise for Pharmaceutical Supply Chain Amid Crisis…
Coronavirus Report – Part 24: Survey Reveals 12 Japanese Pharmaceutical Firms Working to Develop Cures
Coronavirus Report – Part 24: Survey Reveals 12 Japanese…
Coronavirus Report – Part 33: Japan Eyes Development of Five Potential Treatments
Coronavirus Report – Part 33: Japan Eyes Development of Five…
Coronavirus Report – Part 13: Japanese Companies Start to Develop Vaccines, Treatments
Coronavirus Report – Part 13: Japanese Companies Start to…